Brief: Regulus Therapeutics Announces Positive Topline Data

Regulus Therapeutics

24/06/2024 12:12

June 24 (Reuters) - Regulus Therapeutics Inc  RGLS.O :
    * REGULUS THERAPEUTICS ANNOUNCES POSITIVE TOPLINE DATA FROM
THE
THIRD COHORT OF PATIENTS IN ITS PHASE 1B MULTIPLE-ASCENDING DOSE
(MAD) CLINICAL TRIAL OF RGLS8429 FOR THE TREATMENT OF AUTOSOMAL
DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD)
    * REGULUS REPORTS POSITIVE PHASE 1B RESULTS FOR RGLS8429
    * REGULUS THERAPEUTICS INC: EXPLORATORY IMAGING ANALYSES
INDICATED
REDUCTION IN TOTAL KIDNEY VOLUME IN 70% OF PATIENTS DOSED WITH 3
MG/KG
    * REGULUS THERAPEUTICS INC: FOURTH COHORT ENROLLMENT
UNDERWAY

Source text for Eikon:  ID:nPn5r6yNCa 
Further company coverage:  RGLS.O 

 ((Reuters.Briefs@thomsonreuters.com;))